Ein Schwerpunktprogramm der DFG


Publikationen aus dem SPP1313

Rothen-Rutishauser B, Lehmann AD, Clift MJ, Blank F, Gehr P. Laser scanning microscopy combined with image restoration to analyse a 3D model of the human epithelial airway barrier. Swiss Med Wkly, 140:w13060 (2010).

Lehmann AD, Daum N, Lehr CM, Bur M, Gehr P, Rothen-Rutishauser B. An in vitro triple cell co-culture model of the human alveolar epithelial barrier including primary alveolar epithelial cells. Eur J Pharm Biopharm 77: 398-406 (2011).

Raemy DO, Limbach LK, Rothen-Rutishauser B, Grass RN, Gehr P, Birbaum K, Brandenberger Ch, Günthert D, Stark WJ. Cerium oxide nanoparticle uptake kinetics from the gas-phase into lung cell in vitro is transport limited. Eur J Pharm Biopharm 77:368-75 (2011).

Schleh C, Rothen-Rutishauser B, Kreyling WG. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.Eur J Pharm Biopharm. 2011 Apr;77(3):350-2.

Brandenberger Ch, Mühlfeld Ch, Zulqurnain A, Lenz AG, Schmit O, Parak WJ, Gehr P, Rothen-Rutishauser B. Quantitative evaluation of cellular uptake and trafficking of gold nanoparticles with different surface coatings. Small, 6(15):1669-78 (2010).

C. Greulich et al.: Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs); als PDF oder unter folgendem Link:

Barbara Rothen-Rutishauser et al.: Direct Combination of Nanoparticle Fabrication and Exposure to Lung Cell Cultures in a Closed Setup as a Method To Simulate Accidental Nanoparticle Exposure of Humans; als PDF oder unter folgendem Link:

Shirley K. Knauer, Roland H. Stauber:
Kontroverse im "Nanohype": Nanopartikel - Freund oder Feind?
(siehe Downloadsektion)

Stefan Tenzer, Dominic Docter:
Nanoparticle Size Is a Critical Physicochemical Determinant of theHuman Blood Plasma Corona:A Comprehensive Quantitative Proteomic Analysis
(siehe Downloadsektion)